Vivimed Labs Share Price

Vivimed Labs.

CMP as on 27-Nov-20 16:01

₹ 17.00
-0.25 -1.45%

Open

₹ 17.40

Turnover (lac)

₹ 31

Prev. Close

₹ 17.25

Day's Vol (shares)

₹ 1,80,274

Day's Range (₹)

₹ 16.85
₹ 17.55

CMP as on27-Nov-20 15:42

₹ 16.95
-0.3 -1.74%

Open

₹ 17.55

Turnover (lac)

₹ 7

Prev. Close

₹ 17.25

Day's Vol (shares)

₹ 23,078

Day's Range

₹ 16.95
₹ 17.60

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Nov-2020 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2020 ,inter alia, to consider and approve Notice of Board Meeting / Closure of Trading Window Outcome of the Meeting of the Board of Directors of the Company (As Per BSE Announcement Dated 14.11.2020)
Board Meeting - 20-Aug-2020 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2020 ,inter alia, to consider and approve Notice of Board Meeting / Closure of Trading Window Outcome of the Meeting of the Board of Directors of the Company (As Per BSE Announcement Dated 29.08.2020)
Board Meeting - 13-Jul-2020 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to our letters dated 22.06.2020 & 29.06.2020, we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 25th Day of July, 2020 at Hyderabad inter alia to consider and approve, Audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2020. Further, we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.04.2020 to till 48 hours after the declaration of Audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2020. Outcome of the Board Meeting held on July 25, 2020 (As Per BSE Announcement Dated 25.07.2020)
Board Meeting - 22-Jun-2020 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015 we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 29th Day of June, 2020 at Hyderabad inter alia to consider and approve, Audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2020. Further, we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.04.2020 to till 48 hours after the declaration of Audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2020. In Continuation to our previous letter dated 22/06/2020 intimating Stock Exchanges (BSE&NSE) about the Board Meeting which was to be held on Monday, 29th Day of June, 2020 for the approval of Audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2020 stands postponed due to COVID 19 pandemic( the preparation and audit of standalone financial results and consolidation of financial results of subsidiaries has been significantly impacted) Next date of the Board meeting will be informed separately (As Per BSE Announcement Dated on 29-06-2020)
Board Meeting - 08-May-2020 - -
Appointment of Chief Executive Officer
Board Meeting - 30-Jan-2020 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve Notice of Board Meeting for considering un-audited financial results & Closure of Trading Window